Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrand’s Diseases, and Others), and End User (Hospitals, Clinics, and Others)
The blood plasma derivatives market is expected to reach US$ 51,119.24 million by 2028 from US$ 29.886.12 million in 2022; it is estimated to record a CAGR of 9.4% from 2022 to 2028.
The rising prevalence of antibodies deficiencies is driving the blood plasma derivatives market growth. Antibodies deficiency represents the most type of deficiencies in human. Furthermore, increasing geriatric population and rising number of patients suffering from immunodeficiency disorders are fueling the blood plasma derivatives market growth.
Plasma derivatives are obtained from explicit plasma proteins by the cycle of fractionation. Blood plasma derivatives contain a high amount of proteins, salts, minerals, hormones, vitamins, and protease inhibitors. Thus, they are commonly used to destroy viruses that trigger bleeding disorders, hepatitis B, hepatitis C, hemophilia A, immunodeficiency, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus.
Based on type, the blood plasma derivatives market is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Human immunoglobulin (Ig) is used in clinical practices to treat primary immunodeficiencies. Applications of Ig increased rapidly as its anti-inflammatory and immunomodulatory functions were elucidated. Currently, Ig is the most commonly used blood product. It is obtained by processing plasma. These methods help increase the safety and quality of blood products. Ig was first used to treat primary immunodeficiencies; indications for its use have increased greatly over the last 30 years. Therefore, it has become the primary or adjuvant treatment for various autoimmune and inflammatory diseases due to its immunomodulatory and anti-inflammatory properties.
The cases of peripheral nerve injury (PNI) are rising, and the slow regeneration process in PNI patients leads to loss of nerve functions. In addition, research on the mechanism of peripheral nerve regeneration has accelerated significantly, and researchers are seeking different methods to enhance peripheral nerve regeneration. Platelets-rich protein (PRP) therapy integrates mainstream technologies for repairing and rejuvenating the tissues damaged due to injury or chronic diseases. PRP injections have improved regenerative medicine treatments for wound healing, skin regeneration, cosmetic and plastic surgery, and orthopedic procedures in the past few years.
Evidence has shown that micro-needling (MN) and topical application, along with PRP, improve collagen production and skin tightening for vampire facials. According to the report 'Combined micro needling with topical application of platelet-rich plasma versus micro-needling alone in the treatment of stria distensae' published in 2020, MN-PRP was associated with an excellent improvement of skin lesions of Striae distensae (SD), more significant deposition of collagen and elastic fibers, increased proliferative activity in epidermis, and decreased caspase-3 protein expression values in epidermis. It has also been used to treat skin pigmentation disorders and acne scars. In hair transplants, PRP can bind to growth factors and elevates the proliferation of human derma papilla cells leading to the formation and maintenance of hair follicles.
PRP contains a platelet concentrate. A high concentration of platelets can release various growth factors after activation that can promote the proliferation and differentiation of tissue cells, accelerating tissue regeneration. PRP therapy has also been utilized for musculoskeletal regeneration to heal sports and orthopedic-associated injuries. PRP-based treatments have proved beneficial in healing acute hamstring-associated injuries, as per the National Institute of Health (NIH) report.
PRP injections are gaining popularity for treating various conditions, from sports injuries to hair loss. PRP can be widely used in regenerative medicines owing to its tissue regeneration capability, which is likely to provide lucrative opportunities for the blood plasma derivatives market in the coming years
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), National Institute of Biologicals (NIB), and Plasma Protein Therapeutics Association (PPTA) are a few key primary and secondary sources referred to while preparing the report on the blood plasma derivatives market.
The rising prevalence of antibodies deficiencies is driving the blood plasma derivatives market growth. Antibodies deficiency represents the most type of deficiencies in human. Furthermore, increasing geriatric population and rising number of patients suffering from immunodeficiency disorders are fueling the blood plasma derivatives market growth.
Plasma derivatives are obtained from explicit plasma proteins by the cycle of fractionation. Blood plasma derivatives contain a high amount of proteins, salts, minerals, hormones, vitamins, and protease inhibitors. Thus, they are commonly used to destroy viruses that trigger bleeding disorders, hepatitis B, hepatitis C, hemophilia A, immunodeficiency, hypogammaglobulinemia, hemophilia B, and human immunodeficiency virus.
Based on type, the blood plasma derivatives market is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Human immunoglobulin (Ig) is used in clinical practices to treat primary immunodeficiencies. Applications of Ig increased rapidly as its anti-inflammatory and immunomodulatory functions were elucidated. Currently, Ig is the most commonly used blood product. It is obtained by processing plasma. These methods help increase the safety and quality of blood products. Ig was first used to treat primary immunodeficiencies; indications for its use have increased greatly over the last 30 years. Therefore, it has become the primary or adjuvant treatment for various autoimmune and inflammatory diseases due to its immunomodulatory and anti-inflammatory properties.
The cases of peripheral nerve injury (PNI) are rising, and the slow regeneration process in PNI patients leads to loss of nerve functions. In addition, research on the mechanism of peripheral nerve regeneration has accelerated significantly, and researchers are seeking different methods to enhance peripheral nerve regeneration. Platelets-rich protein (PRP) therapy integrates mainstream technologies for repairing and rejuvenating the tissues damaged due to injury or chronic diseases. PRP injections have improved regenerative medicine treatments for wound healing, skin regeneration, cosmetic and plastic surgery, and orthopedic procedures in the past few years.
Evidence has shown that micro-needling (MN) and topical application, along with PRP, improve collagen production and skin tightening for vampire facials. According to the report 'Combined micro needling with topical application of platelet-rich plasma versus micro-needling alone in the treatment of stria distensae' published in 2020, MN-PRP was associated with an excellent improvement of skin lesions of Striae distensae (SD), more significant deposition of collagen and elastic fibers, increased proliferative activity in epidermis, and decreased caspase-3 protein expression values in epidermis. It has also been used to treat skin pigmentation disorders and acne scars. In hair transplants, PRP can bind to growth factors and elevates the proliferation of human derma papilla cells leading to the formation and maintenance of hair follicles.
PRP contains a platelet concentrate. A high concentration of platelets can release various growth factors after activation that can promote the proliferation and differentiation of tissue cells, accelerating tissue regeneration. PRP therapy has also been utilized for musculoskeletal regeneration to heal sports and orthopedic-associated injuries. PRP-based treatments have proved beneficial in healing acute hamstring-associated injuries, as per the National Institute of Health (NIH) report.
PRP injections are gaining popularity for treating various conditions, from sports injuries to hair loss. PRP can be widely used in regenerative medicines owing to its tissue regeneration capability, which is likely to provide lucrative opportunities for the blood plasma derivatives market in the coming years
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), National Institute of Biologicals (NIB), and Plasma Protein Therapeutics Association (PPTA) are a few key primary and secondary sources referred to while preparing the report on the blood plasma derivatives market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Blood Plasma Derivatives Market – by Type
1.3.2 Global Blood Plasma Derivatives Market – by Application
1.3.3 Global Blood Plasma Derivatives Market – by End User
1.3.4 Global Blood Plasma Derivatives Market – by Geography
2. BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – GLOBAL ANALYSIS
6.1 Global Blood Plasma Derivatives Market Revenue Forecast and Analysis
6.2 Global Blood Plasma Derivatives Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Top Market Players
6.4.1 CSL Behring
6.4.2 Grifols, S.A.
7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 Global Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHICAL ANALYSIS
10.1 North America Blood Plasma Derivatives Market
10.1.1 Overview
10.1.2 North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.4 North America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.5 North America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.1.3.1 US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.1.4 US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.5 US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.2.3.1 Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.2.5 Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.3.3.1 Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2 Europe Blood Plasma Derivatives Market
10.2.1 Overview
10.2.2 Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.3.1 Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.4 Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.5 Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6 Europe: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.3.1 Germany: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.6.1.5 Germany Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.3.1 France: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.2.6.2.4 France: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.2.6.2.5 France Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.2.6.3 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.1 Overview2
10.2.6.3.2 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.3 Italy: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.3.3.1 Italy: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.2.6.3.4 Italy: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.3.5 Italy Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
10.2.6.4 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.1 Overview5
10.2.6.4.2 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.3 Spain: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)5
10.2.6.4.3.1 Spain: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.2.6.4.4 Spain: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)6
10.2.6.4.5 Spain Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.2.6.5 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.1 Overview8
10.2.6.5.2 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.3 United Kingdom: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.2.6.5.3.1 United Kingdom: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.2.6.5.4 United Kingdom: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.2.6.5.5 United Kingdom Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.2.6.6 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.1 Overview1
10.2.6.6.2 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.3 Rest of Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.6.3.1 Rest of Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.2.6.6.4 Rest of Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.6.5 Rest of Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3 Asia Pacific Blood Plasma Derivatives Market4
10.3.1 Overview4
10.3.2 Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.3.3 Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)6
10.3.3.1 Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.3.4 Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)7
10.3.5 Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.3.6 Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)8
10.3.6.1 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.1 Overview8
10.3.6.1.2 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.3 Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)9
10.3.6.1.3.1 Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.3.6.1.4 Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.3.6.1.5 Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.3.6.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.1 Overview1
10.3.6.2.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.3 China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.3.6.2.3.1 China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.3.6.2.4 China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.3.6.2.5 China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3.6.3 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.1 Overview4
10.3.6.3.2 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.3 India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.3.6.3.3.1 India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)5
10.3.6.3.4 India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.3.6.3.5 India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)6
10.3.6.4 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.1 Overview7
10.3.6.4.2 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.3 Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.3.6.4.3.1 Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)8
10.3.6.4.4 Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.3.6.4.5 Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.3.6.5 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.1 Overview0
10.3.6.5.2 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.3 South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.3.6.5.3.1 South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.3.6.5.4 South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.3.6.5.5 South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.3.6.6 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.1 Overview3
10.3.6.6.2 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.3 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.3.6.6.3.1 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.3.6.6.4 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.3.6.6.5 Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4 Middle East & Africa Blood Plasma Derivatives Market6
10.4.1 Overview6
10.4.2 Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.4.3 Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.4.3.1 Middle East & Africa: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)8
10.4.4 Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.4.5 Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.4.5.1 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.1 Overview0
10.4.5.1.2 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.3 UAE: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.4.5.1.3.1 UAE: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.4.5.1.4 UAE: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.4.5.1.5 UAE Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.4.5.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.1 Overview3
10.4.5.2.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.3 Saudi Arabia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.4.5.2.3.1 Saudi Arabia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.4.5.2.4 Saudi Arabia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.4.5.2.5 Saudi Arabia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4.5.3 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.1 Overview6
10.4.5.3.2 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.3 South Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.4.5.3.3.1 South Africa: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.4.5.3.4 South Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.4.5.3.5 South Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.4.5.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.1 Overview9
10.4.5.4.2 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.3 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.4.5.4.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)0
10.4.5.4.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.4.5.4.5 Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5 South & Central America Blood Plasma Derivatives Market2
10.5.1 Overview2
10.5.2 South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.5.3 South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.5.3.1 South & Central America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.5.4 South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.5.5 South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.5.5.1 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.1 Overview6
10.5.5.1.2 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.3 Brazil: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.5.5.1.3.1 Brazil: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.5.5.1.4 Brazil: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.5.5.1.5 Brazil Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.5.5.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.1 Overview9
10.5.5.2.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.3 Argentina: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.5.5.2.3.1 Argentina: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.5.5.2.4 Argentina: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.5.5.2.5 Argentina Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5.5.3 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.1 Overview2
10.5.5.3.2 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.3 Rest of South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.5.5.3.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.5.5.3.4 Rest of South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.5.5.3.5 Rest of South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
11. IMPACT OF COVID 19 PANDEMIC ON GLOBAL BLOOD PLASMA DERIVATIVES MARKET5
11.1 North America: Impact Assessment of COVID-19 Pandemic5
11.2 Europe: Impact Assessment of COVID-19 Pandemic7
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic9
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic1
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic3
12. INDUSTRY LANDSCAPE5
12.1 Overview5
12.2 Growth Strategies in the Blood Plasma Derivatives Market5
12.3 Inorganic Growth Strategies5
12.3.1 Overview5
12.4 Organic Growth Strategies7
12.4.1 Overview7
13. COMPANY PROFILES8
13.1 Grifols SA8
13.1.1 Key Facts8
13.1.2 Business Description8
13.1.3 Products and Services8
13.1.4 Financial Overview9
13.1.5 SWOT Analysis0
13.1.6 Key Developments1
13.2 SK Plasma Co Ltd2
13.2.1 Key Facts2
13.2.2 Business Description2
13.2.3 Products and Services2
13.2.4 Financial Overview2
13.2.5 SWOT Analysis3
13.2.6 Key Developments3
13.3 Octapharma AG4
13.3.1 Key Facts4
13.3.2 Business Description4
13.3.3 Products and Services4
13.3.4 Financial Overview5
13.3.5 SWOT Analysis6
13.3.6 Key Developments6
13.4 Monobind Inc.7
13.4.1 Key Facts7
13.4.2 Business Description7
13.4.3 Products and Services7
13.4.4 Financial Overview7
13.4.5 SWOT Analysis8
13.4.6 Key Developments8
13.5 Intas Pharmaceuticals Ltd9
13.5.1 Key Facts9
13.5.2 Business Description9
13.5.3 Products and Services9
13.5.4 Financial Overview9
13.5.5 SWOT Analysis0
13.5.6 Key Developments0
13.6 Fusion Health Care Pvt Ltd1
13.6.1 Key Facts1
13.6.2 Business Description1
13.6.3 Products and Services1
13.6.4 Financial Overview1
13.6.5 SWOT Analysis2
13.6.6 Key Developments2
13.7 Takeda Pharmaceutical Co Ltd3
13.7.1 Key Facts3
13.7.2 Business Description3
13.7.3 Products and Services4
13.7.4 Financial Overview4
13.7.5 SWOT Analysis6
13.7.6 Key Developments6
13.8 CSL Behring LLC7
13.8.1 Key Facts7
13.8.2 Business Description7
13.8.3 Products and Services7
13.8.4 Financial Overview8
13.8.5 SWOT Analysis9
13.8.6 Key Developments9
13.9 LFB SA1
13.9.1 Key Facts1
13.9.2 Business Description1
13.9.3 Products and Services1
13.9.4 Financial Overview1
13.9.5 SWOT Analysis2
13.9.6 Key Developments2
13.10 Kedrion SpA3
13.10.1 Key Facts3
13.10.2 Business Description3
13.10.3 Products and Services3
13.10.4 Financial Overview4
13.10.5 SWOT Analysis5
13.10.6 Key Developments6
14. APPENDIX7
14.1 About The Insight Partners7
14.2 Glossary of Terms7
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Blood Plasma Derivatives Market – by Type
1.3.2 Global Blood Plasma Derivatives Market – by Application
1.3.3 Global Blood Plasma Derivatives Market – by End User
1.3.4 Global Blood Plasma Derivatives Market – by Geography
2. BLOOD PLASMA DERIVATIVES MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. BLOOD PLASMA DERIVATIVES MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. BLOOD PLASMA DERIVATIVES MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increase in Prevalence of Blood Disorders
5.1.2 Rise in Geriatric Population
5.2 Market Restraints
5.2.1 Complicated Reimbursement Policies
5.3 Market Opportunities
5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine
5.4 Future Trends
5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments
5.5 Impact Analysis
6. BLOOD PLASMA DERIVATIVES MARKET – GLOBAL ANALYSIS
6.1 Global Blood Plasma Derivatives Market Revenue Forecast and Analysis
6.2 Global Blood Plasma Derivatives Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Top Market Players
6.4.1 CSL Behring
6.4.2 Grifols, S.A.
7. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Albumin
7.3.1 Overview
7.3.2 Albumin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Factor VIII
7.4.1 Overview
7.4.2 Factor VIII: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Factor IX
7.5.1 Overview
7.5.2 Factor IX: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Immunoglobulin
7.6.1 Overview
7.6.2 Immunoglobulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 IgG
7.6.3.1 Overview
7.6.3.2 IgG: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 IgM
7.6.4.1 Overview
7.6.4.2 IgM: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.5 IgA
7.6.5.1 Overview
7.6.5.2 IgA: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.6 IgD
7.6.6.1 Overview
7.6.6.2 IgD: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.6.7 IgE
7.6.7.1 Overview
7.6.7.2 IgE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Hyperimmune Globulin
7.7.1 Overview
7.7.2 Hyperimmune Globulin: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8. GLOBAL BLOOD PLASMA DERIVATIVES MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
8.1 Overview
8.2 Global Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)
8.3 Hemophilia
8.3.1 Overview
8.3.2 Hemophilia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hypogammaglobulinemia
8.4.1 Overview
8.4.2 Hypogammaglobulinemia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Immunodeficiency Diseases
8.5.1 Overview
8.5.2 Immunodeficiency Diseases: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Von Willebrand Disease
8.6.1 Overview
8.6.2 Von Willebrand Disease: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Applications
8.7.1 Overview
8.7.2 Other Applications: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
9.1 Overview
9.2 Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End Users
9.5.1 Overview
9.5.2 Other End Users: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10. GLOBAL BLOOD PLASMA DERIVATIVES MARKET – REVENUE AND FORECAST TO 2028 – GEOGRAPHICAL ANALYSIS
10.1 North America Blood Plasma Derivatives Market
10.1.1 Overview
10.1.2 North America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.4 North America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.5 North America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.1.3.1 US: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.1.4 US: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.5 US Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.2.3.1 Canada: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.2.5 Canada Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.1.6.3.3.1 Mexico: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2 Europe Blood Plasma Derivatives Market
10.2.1 Overview
10.2.2 Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.3.1 Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.4 Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.5 Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6 Europe: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.3.1 Germany: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)
10.2.6.1.5 Germany Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)
10.2.6.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.3.1 France: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.2.6.2.4 France: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.2.6.2.5 France Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.2.6.3 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.1 Overview2
10.2.6.3.2 Italy: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.2.6.3.3 Italy: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.3.3.1 Italy: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.2.6.3.4 Italy: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.3.5 Italy Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
10.2.6.4 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.1 Overview5
10.2.6.4.2 Spain: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.2.6.4.3 Spain: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)5
10.2.6.4.3.1 Spain: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.2.6.4.4 Spain: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)6
10.2.6.4.5 Spain Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.2.6.5 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.1 Overview8
10.2.6.5.2 United Kingdom: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.2.6.5.3 United Kingdom: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.2.6.5.3.1 United Kingdom: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.2.6.5.4 United Kingdom: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.2.6.5.5 United Kingdom Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.2.6.6 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.1 Overview1
10.2.6.6.2 Rest of Europe: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.2.6.6.3 Rest of Europe: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)2
10.2.6.6.3.1 Rest of Europe: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.2.6.6.4 Rest of Europe: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)3
10.2.6.6.5 Rest of Europe Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3 Asia Pacific Blood Plasma Derivatives Market4
10.3.1 Overview4
10.3.2 Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)5
10.3.3 Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)6
10.3.3.1 Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)6
10.3.4 Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)7
10.3.5 Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)7
10.3.6 Asia Pacific: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)8
10.3.6.1 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.1 Overview8
10.3.6.1.2 Australia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)8
10.3.6.1.3 Australia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)9
10.3.6.1.3.1 Australia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)9
10.3.6.1.4 Australia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)0
10.3.6.1.5 Australia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)0
10.3.6.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.1 Overview1
10.3.6.2.2 China: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)1
10.3.6.2.3 China: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.3.6.2.3.1 China: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)2
10.3.6.2.4 China: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.3.6.2.5 China Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)3
10.3.6.3 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.1 Overview4
10.3.6.3.2 India: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)4
10.3.6.3.3 India: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.3.6.3.3.1 India: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)5
10.3.6.3.4 India: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.3.6.3.5 India Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)6
10.3.6.4 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.1 Overview7
10.3.6.4.2 Japan: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.3.6.4.3 Japan: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.3.6.4.3.1 Japan: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)8
10.3.6.4.4 Japan: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.3.6.4.5 Japan Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.3.6.5 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.1 Overview0
10.3.6.5.2 South Korea: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.3.6.5.3 South Korea: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.3.6.5.3.1 South Korea: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.3.6.5.4 South Korea: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.3.6.5.5 South Korea Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.3.6.6 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.1 Overview3
10.3.6.6.2 Rest of Asia Pacific: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.3.6.6.3 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.3.6.6.3.1 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.3.6.6.4 Rest of Asia Pacific: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.3.6.6.5 Rest of Asia Pacific Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4 Middle East & Africa Blood Plasma Derivatives Market6
10.4.1 Overview6
10.4.2 Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)7
10.4.3 Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)8
10.4.3.1 Middle East & Africa: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)8
10.4.4 Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)9
10.4.5 Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)9
10.4.5.1 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.1 Overview0
10.4.5.1.2 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)0
10.4.5.1.3 UAE: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)1
10.4.5.1.3.1 UAE: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)1
10.4.5.1.4 UAE: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)2
10.4.5.1.5 UAE Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)2
10.4.5.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.1 Overview3
10.4.5.2.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.4.5.2.3 Saudi Arabia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.4.5.2.3.1 Saudi Arabia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.4.5.2.4 Saudi Arabia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.4.5.2.5 Saudi Arabia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.4.5.3 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.1 Overview6
10.4.5.3.2 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.4.5.3.3 South Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.4.5.3.3.1 South Africa: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.4.5.3.4 South Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.4.5.3.5 South Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.4.5.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.1 Overview9
10.4.5.4.2 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.4.5.4.3 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.4.5.4.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)0
10.4.5.4.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.4.5.4.5 Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5 South & Central America Blood Plasma Derivatives Market2
10.5.1 Overview2
10.5.2 South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)3
10.5.3 South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)4
10.5.3.1 South & Central America: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)4
10.5.4 South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)5
10.5.5 South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)5
10.5.5.1 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.1 Overview6
10.5.5.1.2 Brazil: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)6
10.5.5.1.3 Brazil: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)7
10.5.5.1.3.1 Brazil: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)7
10.5.5.1.4 Brazil: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)8
10.5.5.1.5 Brazil Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)8
10.5.5.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.1 Overview9
10.5.5.2.2 Argentina: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)9
10.5.5.2.3 Argentina: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)0
10.5.5.2.3.1 Argentina: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)0
10.5.5.2.4 Argentina: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)1
10.5.5.2.5 Argentina Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)1
10.5.5.3 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.1 Overview2
10.5.5.3.2 Rest of South & Central America: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)2
10.5.5.3.3 Rest of South & Central America: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)3
10.5.5.3.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)3
10.5.5.3.4 Rest of South & Central America: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)4
10.5.5.3.5 Rest of South & Central America Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)4
11. IMPACT OF COVID 19 PANDEMIC ON GLOBAL BLOOD PLASMA DERIVATIVES MARKET5
11.1 North America: Impact Assessment of COVID-19 Pandemic5
11.2 Europe: Impact Assessment of COVID-19 Pandemic7
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic9
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic1
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic3
12. INDUSTRY LANDSCAPE5
12.1 Overview5
12.2 Growth Strategies in the Blood Plasma Derivatives Market5
12.3 Inorganic Growth Strategies5
12.3.1 Overview5
12.4 Organic Growth Strategies7
12.4.1 Overview7
13. COMPANY PROFILES8
13.1 Grifols SA8
13.1.1 Key Facts8
13.1.2 Business Description8
13.1.3 Products and Services8
13.1.4 Financial Overview9
13.1.5 SWOT Analysis0
13.1.6 Key Developments1
13.2 SK Plasma Co Ltd2
13.2.1 Key Facts2
13.2.2 Business Description2
13.2.3 Products and Services2
13.2.4 Financial Overview2
13.2.5 SWOT Analysis3
13.2.6 Key Developments3
13.3 Octapharma AG4
13.3.1 Key Facts4
13.3.2 Business Description4
13.3.3 Products and Services4
13.3.4 Financial Overview5
13.3.5 SWOT Analysis6
13.3.6 Key Developments6
13.4 Monobind Inc.7
13.4.1 Key Facts7
13.4.2 Business Description7
13.4.3 Products and Services7
13.4.4 Financial Overview7
13.4.5 SWOT Analysis8
13.4.6 Key Developments8
13.5 Intas Pharmaceuticals Ltd9
13.5.1 Key Facts9
13.5.2 Business Description9
13.5.3 Products and Services9
13.5.4 Financial Overview9
13.5.5 SWOT Analysis0
13.5.6 Key Developments0
13.6 Fusion Health Care Pvt Ltd1
13.6.1 Key Facts1
13.6.2 Business Description1
13.6.3 Products and Services1
13.6.4 Financial Overview1
13.6.5 SWOT Analysis2
13.6.6 Key Developments2
13.7 Takeda Pharmaceutical Co Ltd3
13.7.1 Key Facts3
13.7.2 Business Description3
13.7.3 Products and Services4
13.7.4 Financial Overview4
13.7.5 SWOT Analysis6
13.7.6 Key Developments6
13.8 CSL Behring LLC7
13.8.1 Key Facts7
13.8.2 Business Description7
13.8.3 Products and Services7
13.8.4 Financial Overview8
13.8.5 SWOT Analysis9
13.8.6 Key Developments9
13.9 LFB SA1
13.9.1 Key Facts1
13.9.2 Business Description1
13.9.3 Products and Services1
13.9.4 Financial Overview1
13.9.5 SWOT Analysis2
13.9.6 Key Developments2
13.10 Kedrion SpA3
13.10.1 Key Facts3
13.10.2 Business Description3
13.10.3 Products and Services3
13.10.4 Financial Overview4
13.10.5 SWOT Analysis5
13.10.6 Key Developments6
14. APPENDIX7
14.1 About The Insight Partners7
14.2 Glossary of Terms7
LIST OF TABLES
Table 1. North America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. France Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)0
Table 27. France Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 28. France Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)1
Table 29. Italy Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 30. Italy Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)3
Table 31. Italy Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 32. Italy Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 33. Spain Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)5
Table 34. Spain Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 35. Spain Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)6
Table 36. Spain Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 37. United Kingdom Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 38. United Kingdom Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 39. United Kingdom Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 40. United Kingdom Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 41. Rest of Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 42. Rest of Europe Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 43. Rest of Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 44. Rest of Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 45. Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)6
Table 46. Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 47. Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)7
Table 48. Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 49. Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)9
Table 50. Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 51. Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 52. Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 53. China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 54. China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 55. China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)2
Table 56. China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 57. India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)4
Table 58. India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)5
Table 59. India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 60. India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 61. Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)7
Table 62. Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 63. Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)8
Table 64. Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 65. South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)0
Table 66. South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 67. South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 68. South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 69. Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)3
Table 70. Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)4
Table 71. Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)4
Table 72. Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)5
Table 73. Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 74. Middle East & Africa Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 75. Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 76. Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 77. UAE Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 78. UAE Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 79. UAE Blood Plasma Derivatives Market, by Application – Revenue and
Table 1. North America Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. France Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)0
Table 27. France Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 28. France Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)1
Table 29. Italy Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 30. Italy Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)3
Table 31. Italy Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 32. Italy Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 33. Spain Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)5
Table 34. Spain Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 35. Spain Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)6
Table 36. Spain Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 37. United Kingdom Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 38. United Kingdom Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 39. United Kingdom Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 40. United Kingdom Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 41. Rest of Europe Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)2
Table 42. Rest of Europe Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 43. Rest of Europe Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 44. Rest of Europe Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 45. Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)6
Table 46. Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)6
Table 47. Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)7
Table 48. Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 49. Australia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)9
Table 50. Australia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)9
Table 51. Australia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)0
Table 52. Australia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 53. China Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 54. China Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)2
Table 55. China Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)2
Table 56. China Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 57. India Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)4
Table 58. India Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)5
Table 59. India Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)5
Table 60. India Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 61. Japan Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)7
Table 62. Japan Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 63. Japan Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)8
Table 64. Japan Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 65. South Korea Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)0
Table 66. South Korea Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 67. South Korea Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)1
Table 68. South Korea Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)2
Table 69. Rest of Asia Pacific Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)3
Table 70. Rest of Asia Pacific Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)4
Table 71. Rest of Asia Pacific Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)4
Table 72. Rest of Asia Pacific Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)5
Table 73. Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)8
Table 74. Middle East & Africa Blood Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)8
Table 75. Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)9
Table 76. Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 77. UAE Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)1
Table 78. UAE Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)1
Table 79. UAE Blood Plasma Derivatives Market, by Application – Revenue and
